Get the Stockscreener App
3.98
0.50%
-0.02
Pre-market:
3.99
0.01
+0.25%
Checkpoint Therapeutics Inc stock is traded at $3.98, with a volume of 7.02M.
It is down -0.50% in the last 24 hours and up +18.81% over the past month.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
See More
Previous Close:
$4.00
Open:
$4
24h Volume:
7.02M
Relative Volume:
2.95
Market Cap:
$194.35M
Revenue:
$103.00K
Net Income/Loss:
$-42.47M
P/E Ratio:
-2.0947
EPS:
-1.9
Net Cash Flow:
$-34.30M
1W Performance:
+59.84%
1M Performance:
+18.81%
6M Performance:
+81.32%
1Y Performance:
+99.00%
1-Day Range:
$3.98
$4.02
1-Week Range:
$2.365
$4.08
52-Week Range:
$1.38
$4.50
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
Name
Checkpoint Therapeutics Inc
Sector
Industry
Phone
781-652-4500
Address
95 SAWYER ROAD, WALTHAM, NY
Compare CKPT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CKPT
Checkpoint Therapeutics Inc
|
3.98 | 194.35M | 103.00K | -42.47M | -34.30M | -1.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.42 | 127.22B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
689.50 | 75.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.45 | 35.94B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.43 | 31.38B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.84 | 26.84B | 3.32B | -860.46M | -1.04B | -8.32 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | D. Boral Capital | Buy |
| Jul-14-22 | Resumed | B. Riley Securities | Buy |
| Jun-09-21 | Initiated | B. Riley Securities | Buy |
| Jan-20-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-19 | Initiated | Lake Street | Buy |
| Dec-08-17 | Initiated | H.C. Wainwright | Buy |
View All
Checkpoint Therapeutics Inc Stock (CKPT) Latest News
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, CKPT, AMPY on Behalf of Shareholders - GlobeNewswire Inc.
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (NasdaqCKPT), Redfin Corporation (NasdaqRDFN), Amplify Energy Corp. (NYSEAMPY), Blackboxstocks Inc. (NasdaqBL - Morningstar
Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest
Checkpoint Therapeutics Target of Unusually Large Options Trading (NASDAQ:CKPT) - Defense World
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Major Acquisition Deal in Pharmaceutical Industry: Sun Pharma to Acquire Checkpoint Therapeutics - Dalal Street Investment Journal
Sun Pharma shares rise over 2 pc as company to acquire Checkpoint Therapeutics - Press Trust of India
3 Penny Stocks to Watch Now, 11/3/25 - TipRanks
Checkpoint Therapeutics (NASDAQ:CKPT) Receives Hold Rating from Lake Street Capital - Defense World
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating - The Financial Express
Sun Pharma to acquire oncology therapy company Checkpoint in US - domain-b.com: The first online Indian business magazine
Checkpoint Therapeutics (NASDAQ:CKPT) Given Buy Rating at D. Boral Capital - Defense World
Sun Pharma to acquire a US-based oncology firm in a deal exceeding ₹3,000 crore - Bizz Buzz
Despite near-term challenges, brokerages remain positive on Sun Pharma - Business Standard
Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - MSN
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - PR Newswire
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Checkpoint Therapeutics, Inc.CKPT - The Malaysian Reserve
Small cap wrap: HIVE, North Bay Resources, GoviEx... - Proactive Investors UK
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details - AOL
Checkpoint Therapeutics shares pop on acquisition by Sun Pharma - Proactive Investors UK
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties (NASDAQ:CKPT) - Seeking Alpha
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher - Benzinga
Checkpoint Therapeutics jumps after deal to be acquired by Sun Pharma - TipRanks
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -- Checkpoint Shares Jump Monday - Marketscreener.com
Sun Pharmaceuticals to Acquire Checkpoint Therapeutics for $355M - Powder Bulk Solids
Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn - DrugsControl.org
Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump - Benzinga
Checkpoint Thera leaps on Sun Pharma takeover bid - The Pharma Letter
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M - FiercePharma
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
Sector Update: Health Care Stocks Flat to Lower Premarket Monday -March 10, 2025 at 09:08 am EDT - Marketscreener.com
CKPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Checkpoint Therapeutics, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
Checkpoint Therapeutics Merges with Sun Pharma for $416M - TipRanks
Top India Drugmaker to Buy US-Based Checkpoint for $355 Million - MSN
Sun Pharma's $355 Million Acquisition of Checkpoint Therapeutics Enhances Specialty PortfolioNews and Statistics - IndexBox, Inc.
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga India
Sun Pharmaceutical (SUNP IN): Checkpoint Acquisition Does Not Check All the Boxes - Smartkarma
Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com
Sun Pharma to buy cash-strapped Checkpoint for $355M upfront - FirstWord Pharma
Checkpoint Therapeutics rises on $355 million Sun Pharma buyout deal - TradingView
Sun Pharma to buy US-based Checkpoint Therapeutics - World Pharmaceutical Frontiers
Sun Sets Up For PD-L1 Play With Checkpoint Acquisition - Scrip
Sun Pharma agrees to acquire Checkpoint Therapeutics - Yahoo Finance
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics - Business Standard
Checkpoint Therapeutics Inc Stock (CKPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):